Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017-Reference-Cited by-同舟云学术

Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017

Published:2018-09-14 Issue:5 Volume:104 Page:940-948
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Ramamoorthy Anuradha¹,Knepper Todd C.²^ORCID,Merenda Christine³,Mendoza Martin³,McLeod Howard L.²^ORCID,Bull Jonca³⁴,Zhang Lei¹⁵,Pacanowski Michael¹

Affiliation:

1. Office of Clinical Pharmacology; Office of Translational Sciences; Center for Drug Evaluation and Research (CDER); U.S. Food and Drug Administration (FDA); Silver Spring Maryland USA

2. Moffitt Cancer Center; Tampa Florida USA

3. Office of Minority Health; Office of the Commissioner; FDA; Silver Spring, Maryland USA

4. Pharmaceutical Product Development (PPD); LLC; Bethesda; Maryland USA

5. Office of Research and Standards; Office of Generic Drugs; CDER; FDA; Silver Spring, Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.1180/fullpdf

Reference50 articles.

1. Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice;Huang;Clin. Pharmacol. Ther.,2008

2. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies;Yasuda;Clin. Pharmacol. Ther.,2008

3. Racial/ethnic differences in drug disposition and response: review of recently approved drugs;Ramamoorthy;Clin. Pharmacol. Ther.,2015

4. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics;Anderson;J. Womens Health (Larchmt.),2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe;European Journal of Cancer;2024-08

2. Racial and Ethnic Disparities in European Breast Cancer Clinical Trials;Cancers;2024-04-29

3. Assessing Ethnic Minority Representation in Fibromyalgia Clinical Trials: A Systematic Review of Recruitment Demographics;International Journal of Environmental Research and Public Health;2023-12-15

4. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?;Clinical Lung Cancer;2023-11

5. Diversity and Representation Among United States Participants in Amgen Clinical Trials;Journal of Racial and Ethnic Health Disparities;2023-09-27